StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research note released on Monday morning. The brokerage issued a hold rating on the stock.
Brooklyn ImmunoTherapeutics Stock Down 3.6 %
NYSE:BTX opened at $0.26 on Monday. The firm has a market capitalization of $15.40 million, a PE ratio of -0.12 and a beta of 4.61. Brooklyn ImmunoTherapeutics has a 12-month low of $0.17 and a 12-month high of $10.10. The firm has a 50-day moving average price of $0.75 and a 200 day moving average price of $1.36.
Brooklyn ImmunoTherapeutics Company Profile
Recommended Stories
- Five stocks we like better than Brooklyn ImmunoTherapeutics
- There Are Different Types of Stock To Invest In
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- NYSE Stocks Give Investors a Variety of Quality Options
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- Learn Technical Analysis Skills to Master the Stock Market
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Brooklyn ImmunoTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brooklyn ImmunoTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
